Stereotactic body radiotherapy for painful spinal metastases - Authors' reply
- PMID: 34478669
- DOI: 10.1016/S1470-2045(21)00459-9
Stereotactic body radiotherapy for painful spinal metastases - Authors' reply
Conflict of interest statement
AS reports consulting fees, honorarium, or both for past educational seminars for Varian Medical Systems, Elekta, AstraZeneca, Medtronic Kyphon, and BrainLAB; and research grants from Elekta and Varian Medical Systems. MB, KD, and WRP declare no competing interests.
Comment on
-
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.Lancet Oncol. 2021 Jul;22(7):1023-1033. doi: 10.1016/S1470-2045(21)00196-0. Epub 2021 Jun 11. Lancet Oncol. 2021. PMID: 34126044 Clinical Trial.
-
Stereotactic body radiotherapy for painful spinal metastases.Lancet Oncol. 2021 Sep;22(9):e384. doi: 10.1016/S1470-2045(21)00421-6. Lancet Oncol. 2021. PMID: 34478668 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
